PetCaseFinder

Peer-reviewed veterinary case report

Cat with severe anemia and low platelets from immune bone marrow

By Zini, Eric et al.·Published in Journal of the American Veterinary Medical Association·2007·Clinic for Small Animal Internal Medicine·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Immune-mediated erythroid and megakaryocytic aplasia in a cat.

Species:
cat

Plain-English summary

A 6-month-old domestic shorthair cat was brought to the vet because it was extremely lethargic. Tests showed the cat had severe anemia (low red blood cells) and low platelet counts, which are important for blood clotting. After trying a common steroid treatment that didn't work, the vet gave the cat human immunoglobulins (a type of immune therapy), which helped improve its blood cell counts. The cat had one relapse but has been stable and healthy for over three years with ongoing treatment.

People also search for: cat lethargy anemia treatment · cat low platelet count · immune-mediated disease in cats

Abstract

CASE DESCRIPTION: A 6-month-old domestic shorthair cat was evaluated because of acute lethargy. CLINICAL FINDINGS: Severe nonregenerative anemia and thrombocytopenia were identified. Cytologic examination of a bone marrow aspirate revealed selective erythroid and mega-karyocytic aplasia and a high number of apparently normal small lymphocytes. Infectious agents implicated in feline hematologic disorders were excluded on the basis of serologic tests or PCR amplification, including FeLV, Ehrlichia canis, Anaplasma phagocytophilum, Mycoplasma haemofelis, Candidatus Mycoplasma haemominutum, and Candidatus Myco-plasma turicensis. TREATMENT AND OUTCOME: A 10-day course of prednisolone administration did not improve the hematologic disorder. Administration of human polyclonal immunoglobulins preceded increased reticulocyte count by 3 days. A second bone marrow examination confirmed restoration of erythroblasts and megakaryocytes. After 1 relapse, the disease was successfully controlled with prednisolone for > 3 years. CLINICAL RELEVANCE: Immune-mediated bone marrow aplasia is rare in cats and usually affects only erythrocyte progenitors. Concomitant involvement of erythroid and megakaryocytic cell lines can be successfully treated via immunosuppressive therapy. Human immunoglobulins seem to be well tolerated in cats; however, proof of a beneficial effect requires further study.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/17397342/